ArticleBMC cardiovascular disorders2025
Association between segmental noninvasive longitudinal strain and quantitative microvascular perfusion in ST-segment elevation myocardial infarction: implications for clinical outcomes.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integration of 2D Speckle Tracking Strain and Clinical Indicators for Early Prediction of Post-PCI Heart Failure in Patients with STEMI and Type 2 Diabetes.International journal of general medicine · 2026Article
- Early Dapagliflozin in Non-diabetic Acute Myocardial Infarction Patients Post-PCI: Effects on Cardiovascular Outcomes and Left Ventricular Remodeling (EARLY DAPA-AMI).Journal of the Saudi Heart Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study aims to investigate the relationship between segmental longitudinal strain (LS) and quantitative microvascular perfusion (qMVP) in patients with ST-segment elevation myocardial infarction (STEMI), and to explore the prognostic value of the two indicators after STEMI.
methodsThe retrospective study enrolled 61 patients who underwent primary percutaneous coronary intervention (pPCI) for first STEMI. Microvascular perfusion (MVP) and qMVP were analyzed by myocardial contrast echocardiography (MCE), and segmental LS was analyzed by two-dimensional speckle tracking echocardiography (2D-STE). Myocardial wall perfusion was qualitatively assessed visually. Quantitative myocardial perfusion parameters were analyzed using an 18-segment model. The correlation between segmental LS and qMVP was assessed. The prognostic value of segmental LS and qMVP for major cardiac adverse events were evaluated.
resultsAmong the 314 segments with abnormal wall motion, 44 showed normal microvascular perfusion (nMVP), 87 showed delayed microvascular perfusion (dMVP), and 183 exhibited microvascular obstruction (MVO). Segmental LS was correlated with segmental wall motion (WM) and qMVP. At 12-month follow-up, 19 patients experienced cardiac events. NT-proBNP, regional LS (rLS), and regional qMVP (r-qMVP) were associated with cardiac events. The area under curve (AUC) of combination of rLS and r-qMVP was bigger than single indicator for identifying prognostic value (P < 0.001).
conclusionSegmental LS indices are correlated with qMVP within the infarct zone following reperfused STEMI. Both rLS and r-qMVP are sensitive to myocardial damage and provide prognostic value for clinical events after STEMI. And the combination of rLS and r-qMVP shows improved predictive ability compared to a single indicator.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.